The DOI matches its Crossref record; 32 of the 32 references it cites were found in a registry or an index.
Surveillance of Resistance to Adamantanes among Influenza A(H3N2) and A(H1N1) Viruses Isolated Worldwide
Abstract
Our previous reports demonstrated an alarming increase in resistance to adamantanes among influenza A(H3N2) viruses isolated in 2001-2005. To continue monitoring drug resistance, we conducted a comprehensive analysis of influenza A(H3N2) and A(H1N1) viruses isolated globally in 2005-2006. The results obtained by pyrosequencing indicate that 96.4% (n=761) of A(H3N2) viruses circulating in the United States were adamantane resistant. Drug resistance has reached 100% among isolates from some Asian countries. Analysis of correlation between the appearance of drug resistance and the evolutionary pathway of the hemagglutinin (HA) gene suggests at least 2 separate introductions of resistance into circulating populations that gave rise to identifiable subclades. It also indicates that resistant A(H3N2) viruses may have emerged in Asia in late 2001. Among A(H1N1) viruses isolated worldwide, resistance reached 15.5% in 2005-2006; in the United States alone, it was 4.0%. Phylogenetic analysis of the HA and M genes indicates that the acquisition of resistance in A(H1N1) viruses can be linked to a specific genetic group and was not a result of reassortment between A(H3N2) and A(H1N1) viruses. The results of the study highlight the necessity of close monitoring of resistance to existing antivirals as wells as the need for new therapeutics.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
MEGA3: Integrated software for Molecular Evolutionary Genetics Analysis and sequence alignment
Kumar, S. (2004) · Briefings in Bioinformatics · doi:10.1093/bib/5.2.150 · Cited by 11,756
(2001) · PsycEXTRA Dataset · doi:10.1037/e548312006-001 · Cited by 5,011
Mortality Associated With Influenza and Respiratory Syncytial Virus in the United States
Thompson, W. W., Shay, D. K., Weintraub, E., Brammer, L., Cox, N., Anderson, L. J., & Fukuda, K. (2003) · JAMA · doi:10.1001/jama.289.2.179 · Cited by 3,673
Self-citationRowe, T., Abernathy, R. A., Hu-Primmer, J., Thompson, W. W., Lu, X., Lim, W., Fukuda, K., Cox, N. J., & Katz, J. M. (1999) · Journal of Clinical Microbiology · doi:10.1128/jcm.37.4.937-943.1999 · Cited by 811
Self-citationResistant influenza A viruses in children treated with oseltamivir: descriptive study
Kiso, M., Mitamura, K., Sakai-Tagawa, Y., Shiraishi, K., Kawakami, C., Kimura, K., Hayden, F. G., Sugaya, N., & Kawaoka, Y. (2004) · The Lancet · doi:10.1016/s0140-6736(04)16934-1 · Cited by 786
Influenza virus neuraminidase inhibitors
Gubareva, L. V., Kaiser, L., & Hayden, F. G. (2000) · The Lancet · doi:10.1016/s0140-6736(99)11433-8 · Cited by 730
Self-citationBright, R. A., Medina, M.-J., Xu, X., Perez-Oronoz, G., Wallis, T. R., Davis, X. M., Povinelli, L., Cox, N. J., & Klimov, A. I. (2005) · The Lancet · doi:10.1016/s0140-6736(05)67338-2 · Cited by 725
Self-citationOral oseltamivir treatment of influenza in children
WHITLEY, R. J., HAYDEN, F. G., REISINGER, K. S., YOUNG, N., DUTKOWSKI, R., IPE, D., MILLS, R. G., & WARD, P. (2001) · The Pediatric Infectious Disease Journal · doi:10.1097/00006454-200102000-00002 · Cited by 711
Bright, R. A. (2006) · JAMA · doi:10.1001/jama.295.8.joc60020 · Cited by 671
Self-citation(2013) · Wiley eBooks · doi:10.1002/9781118636817 · Cited by 653
A controlled trial of amantadine and rimantadine in the prophylaxis of influenza A infection
Dolin, R., Reichman, R. C., Madore, H. P., Maynard, R., Linton, P. N., & Webber-Jones, J. (1982) · New England Journal of Medicine · doi:10.1056/nejm198209023071002 · Cited by 501
Emergence and Apparent Transmission of Rimantadine-Resistant Influenza A Virus in Families
Hayden, F. G., Belshe, R. B., Clover, R. D., Hay, A. J., Oakes, M. G., & Soo, W. (1989) · New England Journal of Medicine · doi:10.1056/nejm198912213212502 · Cited by 416
Interpandemic Influenza in the Houston Area, 1974–76
Glezen, W. P., Couch, R. B., MacLean, R. A., Payne, A., Baird, J. N., Vallbona, C., Tristan, M., & Byrd, N. (1978) · New England Journal of Medicine · doi:10.1056/nejm197803162981103 · Cited by 386
Inhaled Zanamivir for the Prevention of Influenza in Families
Hayden, F. G., Gubareva, L. V., Monto, A. S., Klein, T. C., Elliott, M. J., Hammond, J. M., Sharp, S. J., & Ossi, M. J. (2000) · New England Journal of Medicine · doi:10.1056/nejm200011023431801 · Cited by 371
Self-citationMonto, A. S., McKimm-Breschkin, J. L., Macken, C., Hampson, A. W., Hay, A., Klimov, A., Tashiro, M., Webster, R. G., Aymard, M., Hayden, F. G., et al. (2006) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01339-05 · Cited by 364
Self-citationGenetic basis of resistance to rimantadine emerging during treatment of influenza virus infection
Belshe, R. B., Smith, M. H., Hall, C. B., Betts, R., & Hay, A. J. (1988) · Journal of Virology · doi:10.1128/jvi.62.5.1508-1512.1988 · Cited by 287
INFLUENZAVIRUS INFECTIONS IN SEAVFLE FAMILIES, 1975–1979
FOX, J. P., HALL, C. E., COONEY, M. K., & FOY, H. M. (1982) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a113407 · Cited by 261
Bridges, C. B., Harper, S. A., Fukuda, K., Uyeki, T. M., Cox, N. J., & Singleton, J. A. (2002) · Jagiellonian University Repository (Jagiellonian University) · Cited by 213
Self-citationINFLUENZAVIRUS INFECTIONS IN SEATTLE FAMILIES, 1975–1979
FOX, J. P., COONEY, M. K., HALL, C. E., & FOY, H. M. (1982) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a113408 · Cited by 196
(2000) · PsycEXTRA Dataset · doi:10.1037/e548102006-001 · Cited by 178
Klimov, A. I., Rocha, E., Hayden, F. G., Shult, P. A., Roumillat, L. F., & Cox, N. J. (1995) · Journal of Infectious Diseases · doi:10.1093/infdis/172.5.1352 · Cited by 177
Self-citationResistance of Influenza A Virus to Amantadine and Rimantadine: Results of One Decade of Surveillance
Belshe, R. B., Burk, B., Newman, F., Cerruti, R. L., & Sim, I. S. (1989) · The Journal of Infectious Diseases · doi:10.1093/infdis/159.3.430 · Cited by 174
Shaw, M. W., Xu, X., Li, Y., Normand, S., Ueki, R. T., Kunimoto, G. Y., Hall, H., Klimov, A., Cox, N. J., & Subbarao, K. (2002) · Virology · doi:10.1006/viro.2002.1719 · Cited by 171
Self-citationPermeation and Activation of the M2 Ion Channel of Influenza A Virus
Mould, J. A., Drury, J. E., Frings, S., Kaupp, U. B., Pekosz, A. S., Lamb, R. A., & Pinto, L. H. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m003663200 · Cited by 155
Rimantadine Hydrochloride and Amantadine Hydrochloride Use in Influenza A Virus Infections
Tominack, R. L., & Hayden, F. G. (1987) · Infectious Disease Clinics of North America · doi:10.1016/s0891-5520(20)30120-3 · Cited by 117
Low Incidence of Rimantadine Resistance in Field Isolates of Influenza A Viruses
Ziegler, T. T., Hemphill, M. L., Ziegler, M., Perez‐Oronoz, G., Klimov, A. I., Hampson, A. W., Regnery, H. L., & Cox, N. J. (1999) · The Journal of Infectious Diseases · doi:10.1086/314994 · Cited by 113
Self-citationPerspectives on antiviral use during pandemic influenza
Hayden, F. G. (2001) · Philosophical Transactions of the Royal Society B Biological Sciences · doi:10.1098/rstb.2001.1007 · Cited by 109
Barnett, J. M., Cadman, A., Gor, D., Dempsey, M. H., Walters, M. S., Candlin, A., Tisdale, M., Morley, P. J., Owens, I. J., Fenton, R. J., et al. (2000) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.44.1.78-87.2000 · Cited by 104
Reassortment and evolution of current human influenza A and B viruses
Xu, X., Lindstrom, S., Shaw, M. W., Smith, C. B., Hall, H. E., Mungall, B. A., Subbarao, K., Cox, N. J., & Klimov, A. I. (2004) · Virus Research · doi:10.1016/j.virusres.2004.02.013 · Cited by 88
Self-citationBoivin, G., Goyette, N., & Bernatchez, H. (2002) · Clinical Infectious Diseases · doi:10.1086/338870 · Cited by 86
Antiviral therapy of influenza
Englund, J. A. (2002) · Seminars in Pediatric Infectious Diseases · doi:10.1053/spid.2002.122999 · Cited by 64
Mills, J., & Crowe, S. (2010) · CRC Press eBooks · doi:10.1201/b13787-294 · Cited by 17
Cited by
Krammer, F., Smith, G. J. D., Fouchier, R. A. M., Peiris, M., Kedzierska, K., Doherty, P. C., Palese, P., Shaw, M. L., Treanor, J., Webster, R. G., et al. (2018) · Nature Reviews Disease Primers · doi:10.1038/s41572-018-0002-y · Cited by 1,570
Self-citationHarper, S. A., Bradley, J. S., Englund, J. A., File, T. M., Gravenstein, S., Hayden, F. G., McGeer, A. J., Neuzil, K. M., Pavia, A. T., Tapper, M. L., et al. (2009) · Clinical Infectious Diseases · doi:10.1086/598513 · Cited by 647
Structural basis for the function and inhibition of an influenza virus proton channel
Stouffer, A. L., Acharya, R., Salom, D., Levine, A. S., Di Costanzo, L., Soto, C. S., Tereshko, V., Nanda, V., Stayrook, S., & DeGrado, W. F. (2008) · Nature · doi:10.1038/nature06528 · Cited by 636
Sheu, T. G., Deyde, V. M., Okomo-Adhiambo, M., Garten, R. J., Xu, X., Bright, R. A., Butler, E. N., Wallis, T. R., Klimov, A. I., & Gubareva, L. V. (2008) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00555-08 · Cited by 480
Self-citationDrug resistance in influenza A virus: the epidemiology and management
Hussain, M., Galvin, H., Haw, T. Y., Nutsford, A., & Husain, M. (2017) · Infection and Drug Resistance · doi:10.2147/idr.s105473 · Cited by 439
Metadata
- Authors
- Deyde, V. M., Xu, X., Bright, R. A., Shaw, M., Smith, C. B., Zhang, Y., Shu, Y., Gubareva, L. V., Cox, N. J., & Klimov, A. I.
- Venue
- The Journal of Infectious Diseases
- Publisher
- Oxford University Press (OUP)
- Published
- 2007-07-15
- Volume
- 196
- Issue
- 2
- Pages
- 249-257
- ISSN
- 0022-1899 (ISSN-L)
- 1537-6613
- OpenAlex
- W2138198678
- Cited by
- 543
- References
- 32
- FWCI
- 33.29
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.